Logo Lanfrica

Xenophobia’s Contours During an Ebola Epidemic: Proximity and the Targeting of Peul Migrants in Senegal

Domain:

peace and security

Record type:

paper
Creator:
Ato
Publisher:
Cam
Host:
Abstract: This article examines the effect of geographical proximity on targeting patterns during Ebola-era xenophobic outbursts by Senegalese against a migrant Peul population of Guinean origins. It highlights the limited extent to which epidemics shape the micro-dynamics of outbreaks of xenophobia during public health crises, demonstrating that epidemics are not defining events that inflect inter-group relations. They mostly reinforce long-persisting patterns of exclusion. The conclusion is that the contours of xenophobia in contexts marked by public health crises and in those situations in which these issues of public health do not constitute a major concern tend to mirror each other.

Languages

Fulfulde, AdamawaFulfulde, BorguFulfulde, Central-Eastern NigerFulfulde, MaasinaFulfulde, NigerianFulfulde, Western NigerPulaar

Licenses

https://www.cambridge.org/core/termshttps://www.cambridge.org/core/terms

Similar

Contextualizing mobility during the Ebola epidemic in Liberia

Based on findings from focus groups and key informant interviews conducted at five sites in Liberia

Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges

The index case of the Ebola virus disease epidemic in West Africa is believed to have originated in

The network epidemiology of an Ebola epidemic

Connecting the different scales of epidemic dynamics, from individuals to communities to nations, re

Antiretroviral Medication Adherence During The Ebola Epidemic In Sierra Leone

Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola

Abstract The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE), an Ebola vaccine tri

Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola Virus Disease epidemic

The first Phase II and III clinical trials for treatments for Ebola Virus Disease were conducted dur